• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠乳腺癌细胞系 C-127I、EMT6/P 和 TA3 Hauschka 的分子细胞遗传学特征。

Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka.

机构信息

Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Am Klinikum 1, D-07747 Jena, Germany.

Croatian Institute for Brain Research, School of Medicine University of Zagreb, Salata 12, 10000 Zagreb, Croatia.

出版信息

Int J Mol Sci. 2020 Jul 1;21(13):4716. doi: 10.3390/ijms21134716.

DOI:10.3390/ijms21134716
PMID:32630352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7369978/
Abstract

BACKGROUND

To test and introduce effective and less toxic breast cancer (BC) treatment strategies, animal models, including murine BC cell lines, are considered as perfect platforms. Strikingly, the knowledge on the genetic background of applied BC cell lines is often sparse though urgently necessary for their targeted and really justified application.

METHODS

In this study, we performed the first molecular cytogenetic characterization for three murine BC cell lines C-127I, EMT6/P and TA3 Hauschka. Besides fluorescence in situ hybridization-banding, array comparative genomic hybridization was also applied. Thus, overall, an in silico translation for the detected imbalances and chromosomal break events in the murine cell lines to the corresponding homologous imbalances in humans could be provided. The latter enabled a comparison of the murine cell line with human BC cytogenomics.

RESULTS

All three BC cell lines showed a rearranged karyotype at different stages of complexity, which can be interpreted carefully as reflectance of more or less advanced tumor stages.

CONCLUSIONS

Accordingly, the C-127I cell line would represent the late stage BC while the cell lines EMT6/P and TA3 Hauschka would be models for the premalignant or early BC stage and an early or benign BC, respectively. With this cytogenomic information provided, these cell lines now can be applied really adequately in future research studies.

摘要

背景

为了测试和引入有效且毒性较小的乳腺癌(BC)治疗策略,动物模型,包括鼠类 BC 细胞系,被认为是完美的平台。然而,尽管对于这些细胞系的靶向和合理应用非常必要,但有关应用的 BC 细胞系遗传背景的知识往往非常匮乏。

方法

在这项研究中,我们对三种鼠类 BC 细胞系 C-127I、EMT6/P 和 TA3 Hauschka 进行了首次分子细胞遗传学特征分析。除了荧光原位杂交带型分析外,还应用了比较基因组杂交阵列。因此,可以对在鼠类细胞系中检测到的不平衡和染色体断裂事件进行计算机翻译,将其转换为人类相应的同源不平衡。后者可以将鼠类细胞系与人类 BC 细胞遗传学进行比较。

结果

三种 BC 细胞系均表现出不同程度复杂性的重排核型,可以仔细解释为或多或少高级肿瘤阶段的反映。

结论

因此,C-127I 细胞系代表晚期 BC,而 EMT6/P 和 TA3 Hauschka 细胞系分别代表前恶性或早期 BC 阶段和早期或良性 BC 阶段。有了这些提供的细胞遗传学信息,这些细胞系现在可以在未来的研究中得到更充分的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/339ba8f1d95a/ijms-21-04716-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/886891642eb4/ijms-21-04716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/e5dd026637c7/ijms-21-04716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/d374a49bece8/ijms-21-04716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/b6e705f98611/ijms-21-04716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/4bb1d5081f47/ijms-21-04716-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/339ba8f1d95a/ijms-21-04716-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/886891642eb4/ijms-21-04716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/e5dd026637c7/ijms-21-04716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/d374a49bece8/ijms-21-04716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/b6e705f98611/ijms-21-04716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/4bb1d5081f47/ijms-21-04716-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a53e/7369978/339ba8f1d95a/ijms-21-04716-g006.jpg

相似文献

1
Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka.鼠乳腺癌细胞系 C-127I、EMT6/P 和 TA3 Hauschka 的分子细胞遗传学特征。
Int J Mol Sci. 2020 Jul 1;21(13):4716. doi: 10.3390/ijms21134716.
2
Cytogenomic characteristics of murine breast cancer cell line JC.小鼠乳腺癌细胞系JC的细胞基因组特征
Mol Cytogenet. 2021 Feb 1;14(1):7. doi: 10.1186/s13039-020-00524-z.
3
Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting.结合G显带、比较基因组杂交、多色荧光原位杂交、RxFISH和染色体特异性描绘技术对人乳腺癌细胞系MA11进行完整的细胞遗传学特征分析。
Cancer Genet Cytogenet. 2001 Nov;131(1):25-30. doi: 10.1016/s0165-4608(01)00484-8.
4
Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.雌激素受体、孕激素受体及人表皮生长因子受体2在乳腺癌细针穿刺抽吸细胞块及配对组织学标本中的表达:一项大型回顾性研究。
Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17.
5
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines.三种小鼠恶性间皮瘤肿瘤细胞系的细胞基因组特征分析
Mol Cytogenet. 2020 Sep 9;13:43. doi: 10.1186/s13039-020-00511-4. eCollection 2020.
6
Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.约旦乳腺癌中人表皮生长因子受体2及雌激素和孕激素受体的免疫组织化学评估
Breast Cancer Res. 2005;7(5):R598-604. doi: 10.1186/bcr1200. Epub 2005 May 24.
7
Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.评估血清中miRNAs 9和342的表达作为乳腺癌的诊断和预后生物标志物。
Breast Dis. 2021;40(4):241-250. doi: 10.3233/BD-201076.
8
Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line.恶性原始神经外胚层 SK-PN-DW 肿瘤细胞系的细胞遗传学特征。
BMC Cancer. 2019 May 2;19(1):412. doi: 10.1186/s12885-019-5625-1.
9
Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome- and locus-specific FISH.通过联合应用G显带、R显带、多色荧光原位杂交(M-FISH)、比较基因组杂交(CGH)以及染色体和基因座特异性荧光原位杂交对七种人类癌细胞系进行细胞遗传学特征分析。
Int J Mol Med. 2004 Oct;14(4):483-95.
10
Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.雌激素受体、孕激素受体、卵泡抑素和人表皮生长因子受体2靶向分子探针在乳腺癌患者磁共振成像中的诊断价值
Cell Physiol Biochem. 2018;49(1):271-281. doi: 10.1159/000492877. Epub 2018 Aug 23.

引用本文的文献

1
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.基于纳米医学的乳腺癌治疗与管理递药策略。
Int J Mol Sci. 2022 Mar 5;23(5):2856. doi: 10.3390/ijms23052856.
2
Molecular cytogenetic characterization of the urethane-induced murine lung cell line LA-4 as a model for human squamous cell lung cancer.将氨基甲酸乙酯诱导的小鼠肺细胞系LA-4作为人类肺鳞状细胞癌模型的分子细胞遗传学特征分析
Mol Clin Oncol. 2022 Jan;16(1):9. doi: 10.3892/mco.2021.2440. Epub 2021 Nov 14.
3
Cytogenomic characteristics of murine breast cancer cell line JC.

本文引用的文献

1
Clinical Decision Support Systems in Breast Cancer: A Systematic Review.乳腺癌临床决策支持系统:一项系统综述。
Cancers (Basel). 2020 Feb 6;12(2):369. doi: 10.3390/cancers12020369.
2
The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid.联合应用 P 糖蛋白调节剂依利格鲁司他对拉帕替尼的药代动力学及其在脑和脑脊液中分布的影响。
Invest New Drugs. 2020 Jun;38(3):574-583. doi: 10.1007/s10637-019-00806-3. Epub 2019 Jun 8.
3
Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
小鼠乳腺癌细胞系JC的细胞基因组特征
Mol Cytogenet. 2021 Feb 1;14(1):7. doi: 10.1186/s13039-020-00524-z.
4
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines.三种小鼠恶性间皮瘤肿瘤细胞系的细胞基因组特征分析
Mol Cytogenet. 2020 Sep 9;13:43. doi: 10.1186/s13039-020-00511-4. eCollection 2020.
阵列比较基因组杂交分析揭示染色体拷贝数改变可作为淋巴结阴性乳腺癌患者预后的指标。
BMC Cancer. 2019 May 30;19(1):521. doi: 10.1186/s12885-019-5737-7.
4
FISH and HER2/ equivocal immunohistochemistry in breast carcinoma.乳腺癌中的荧光原位杂交(FISH)及人表皮生长因子受体2(HER2)/免疫组化结果不明确
Indian J Cancer. 2019 Apr-Jun;56(2):119-123. doi: 10.4103/ijc.IJC_333_18.
5
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.基于乳腺癌分子特征的治疗靶点的最新进展:基因突变及其对当前治疗模式的影响。
J Hematol Oncol. 2019 Apr 11;12(1):38. doi: 10.1186/s13045-019-0725-6.
6
Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines.纽卡斯尔病病毒使小鼠实体瘤消退与凋亡相关细胞因子的产生有关。
BMC Cancer. 2019 Apr 4;19(1):315. doi: 10.1186/s12885-019-5516-5.
7
Patterns of Genomic Instability in Breast Cancer.乳腺癌中的基因组不稳定性模式。
Trends Pharmacol Sci. 2019 Mar;40(3):198-211. doi: 10.1016/j.tips.2019.01.005. Epub 2019 Feb 6.
8
Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.整合拷贝数和基因表达数据的分析确定了潜在的致癌驱动因素,这些因素促进了乳腺肿瘤的复发。
Genes Chromosomes Cancer. 2019 Jun;58(6):381-391. doi: 10.1002/gcc.22729. Epub 2019 Jan 30.
9
Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.南非患者原发性乳腺癌的拷贝数改变模式及其对功能细胞通路的影响。
Int J Oncol. 2018 Dec;53(6):2745-2757. doi: 10.3892/ijo.2018.4589. Epub 2018 Oct 10.
10
Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network.利用生物信息学分析和微阵列遗传相互作用网络探索与乳腺癌骨转移相关的分子机制。
Medicine (Baltimore). 2018 Sep;97(37):e12032. doi: 10.1097/MD.0000000000012032.